Illuminating circuitry relevant to psychiatric disorders with optogenetics
- PMID: 25215625
- PMCID: PMC4293223
- DOI: 10.1016/j.conb.2014.08.004
Illuminating circuitry relevant to psychiatric disorders with optogenetics
Abstract
The brain's remarkable capacity to generate cognition and behavior is mediated by an extraordinarily complex set of neural interactions that remain largely mysterious. This complexity poses a significant challenge in developing therapeutic interventions to ameliorate psychiatric disease. Accordingly, few new classes of drugs have been made available for patients with mental illness since the 1950s. Optogenetics offers the ability to selectively manipulate individual neural circuit elements that underlie disease-relevant behaviors and is currently accelerating the pace of preclinical research into neurobiological mechanisms of disease. In this review, we highlight recent findings from studies that employ optogenetic approaches to gain insight into normal and aberrant brain function relevant to mental illness. Emerging data from these efforts offers an exquisitely detailed picture of disease-relevant neural circuits in action, and hints at the potential of optogenetics to open up entirely new avenues in the treatment of psychiatric disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Conflict of interest statement
K.D. and R.C.M. are co-founders of a company, Circuit Therapeutics, Inc., the goals of which are to use optogenetics to improve the drug development process and to develop novel devices to treat disorders of the peripheral and central nervous systems. They are both on the scientific advisory board for Circuit Therapeutics, Inc.
Similar articles
-
Optogenetic dissection of cortical information processing-shining light on schizophrenia.Brain Res. 2012 Oct 2;1476:31-7. doi: 10.1016/j.brainres.2012.04.015. Epub 2012 Apr 17. Brain Res. 2012. PMID: 22578471 Review.
-
Spotlight on movement disorders: What optogenetics has to offer.Mov Disord. 2015 Apr 15;30(5):624-31. doi: 10.1002/mds.26184. Epub 2015 Mar 17. Mov Disord. 2015. PMID: 25777796 Free PMC article.
-
Optogenetically-inspired neuromodulation: Translating basic discoveries into therapeutic strategies.Int Rev Neurobiol. 2021;159:187-219. doi: 10.1016/bs.irn.2021.06.002. Epub 2021 Jul 21. Int Rev Neurobiol. 2021. PMID: 34446246 Review.
-
Optogenetics and deep brain stimulation neurotechnologies.Handb Exp Pharmacol. 2015;228:441-50. doi: 10.1007/978-3-319-16522-6_15. Handb Exp Pharmacol. 2015. PMID: 25977092 Review.
-
Neural networks in psychiatry.Eur Neuropsychopharmacol. 2013 Jan;23(1):1-6. doi: 10.1016/j.euroneuro.2012.12.004. Epub 2013 Feb 8. Eur Neuropsychopharmacol. 2013. PMID: 23394870 Review.
Cited by
-
Optogenetic dissection of medial prefrontal cortex circuitry.Front Syst Neurosci. 2014 Dec 9;8:230. doi: 10.3389/fnsys.2014.00230. eCollection 2014. Front Syst Neurosci. 2014. PMID: 25538574 Free PMC article. Review.
-
Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits.Pain. 2016 Nov;157(11):2424-2433. doi: 10.1097/j.pain.0000000000000620. Pain. 2016. PMID: 27340912 Free PMC article. Review. No abstract available.
-
Neuroanatomic and Functional Neuroimaging Findings.Curr Top Behav Neurosci. 2021;48:173-196. doi: 10.1007/7854_2020_174. Curr Top Behav Neurosci. 2021. PMID: 33040316
-
Bibliography: Clinical Neuropsychiatry.Focus (Am Psychiatr Publ). 2016 Oct;14(4):488-489. doi: 10.1176/appi.focus.140404. Epub 2016 Oct 7. Focus (Am Psychiatr Publ). 2016. PMID: 31975831 Free PMC article. No abstract available.
-
Deep Brain Stimulation in Psychiatry: Mechanisms, Models, and Next-Generation Therapies.Psychiatr Clin North Am. 2018 Sep;41(3):373-383. doi: 10.1016/j.psc.2018.04.003. Epub 2018 Jul 9. Psychiatr Clin North Am. 2018. PMID: 30098651 Free PMC article. Review.
References
-
- Nestler EJ. Antidepressant treatments in the 21st century. Biol Psychiatry. 1998;44:526–33. - PubMed
-
- Hyman SE. Revitalizing psychiatric therapeutics. Neuropsychopharmacology. 2014;39:220–9. A frank and insightful discussion of the practical and scientific obstacles to developing new therapies for psychiatric disorders, with a focus on new technologies that have the potential to circumvent these challenges. - PMC - PubMed
-
- Weaver DF, Weaver CA. Exploring neurotherapeutic space: how many neurological drugs exist (or could exist)? J Pharm Pharmacol. 2011;63:136–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical